Dual Checkpoint Blockade in a Neuroendocrine Carcinoma With Dual PD-L1/PD-L2 Amplification and High Tumor Mutational Burden

被引：1
|
作者：
Gong, Jun [1 ]
Patel, Sandip [2 ]
Adashek, Jacob J. [3 ]
Frishberg, David [4 ]
Guan, Michelle [1 ]
Placencio-Hickok, Veronica R. [1 ]
Gangi, Alexandra [5 ]
Gresham, Gillian [1 ]
Tuli, Richard [6 ,7 ]
Chae, Young K. [8 ]
Kurzrock, Razelle [2 ]
Hendifar, Andrew E. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Med, Div Med Oncol, Los Angeles, CA 90048 USA
[2] Univ Calif San Diego, Moores Canc Ctr, Div Hematol Oncol, La Jolla, CA 92093 USA
[3] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA
[4] Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA
[5] Cedars Sinai Med Ctr, Div Surg Oncol & Hepatobiliary Surg, Dept Surg, Los Angeles, CA 90048 USA
[6] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Radiat Oncol, Los Angeles, CA 90048 USA
[7] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Dept Biomed Sci, Los Angeles, CA 90048 USA
[8] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
来源：
JCO PRECISION ONCOLOGY | 2020年 / 4卷
基金：
美国国家卫生研究院;
关键词：
CELL LUNG-CANCER; PEMBROLIZUMAB; NIVOLUMAB; IMPACT; PD-L1;
D O I：
10.1200/PO.18.00391
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：514 / 519
页数：6
相关论文
共 50 条
  • [21] Role of PD-L1 and PD-L2 in allergic diseases and asthma
    Singh, A. K.
    Stock, P.
    Akbari, O.
    ALLERGY, 2011, 66 (02) : 155 - 162
  • [22] Regulation of Immunity in Clear Cell Renal Carcinoma: Role of PD-1, PD-L1, and PD-L2
    Spirina, Liudmila
    Yurmazov, Zahar
    Usynin, Evgeny
    Kondakova, Irina
    Ladutko, Ekaterine
    Choynzonov, Evgeny
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2021, 43 (02) : 1072 - 1080
  • [23] Erratum to: PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
    Dimitrios Mathios
    Jacob Ruzevick
    Christopher M. Jackson
    Haiying Xu
    Sagar R. Shah
    Janis M. Taube
    Peter C. Burger
    Edward F. McCarthy
    Alfredo Quinones-Hinojosa
    Drew M. Pardoll
    Michael Lim
    Journal of Neuro-Oncology, 2016, 128 : 183 - 183
  • [24] Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden
    Morrison, Carl
    Pabla, Sarabjot
    Conroy, Jeffrey M.
    Nesline, Mary K.
    Glenn, Sean T.
    Dressman, Devin
    Papanicolau-Sengos, Antonios
    Burgher, Blake
    Andreas, Jonathan
    Giamo, Vincent
    Qin, Moachun
    Wang, Yirong
    Lenzo, Felicia L.
    Omilian, Angela
    Bshara, Wiam
    Zibelman, Matthew
    Ghatalia, Pooja
    Dragnev, Konstantin
    Shirai, Keisuke
    Madden, Katherine G.
    Tafe, Laura J.
    Shah, Neel
    Kasuganti, Deepa
    de la Cruz-Merino, Luis
    Araujo, Isabel
    Saenger, Yvonne
    Bogardus, Margaret
    Villalona-Calero, Miguel
    Diaz, Zuanel
    Day, Roger
    Eisenberg, Marcia
    Anderson, Steven M.
    Puzanov, Igor
    Galluzzi, Lorenzo
    Gardner, Mark
    Ernstoff, Marc S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2018, 6
  • [25] Tumor mutational burden related classifier is predictive of response to PD-L1 blockade in locally advanced and metastatic urothelial carcinoma
    Wang, Yejinpeng
    Chen, Liang
    Ju, Lingao
    Xiao, Yu
    Wang, Xinghuan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 87
  • [26] PD-L1 blockade for urothelial carcinoma
    Kang, Josephine
    Galluzzi, Lorenzo
    ONCOIMMUNOLOGY, 2017, 6 (07):
  • [27] PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
    Ghiotto, Marguerite
    Gauthier, Laurent
    Serriari, Nacer
    Pastor, Sonia
    Truneh, Alemseged
    Nunes, Jacques A.
    Olive, Daniel
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (08) : 651 - 660
  • [28] PD-1, PD-L1 and PD-L2 expression in mouse prostate cancer
    Yang, Shijie
    Zhang, Qiuyang
    Liu, Sen
    Wang, Alun R.
    You, Zongbing
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2016, 4 (01): : 1 - 8
  • [29] Immune Checkpoint (PD-1, PD-L1, PD-L2, and CTLA-4) Expression in Plasma Cell Myeloma
    Lee, Min Young
    Park, Chan-jeoung
    Cho, Young-Uk
    You, Eunkyoung
    Jang, Seongsoo
    Lee, Jung-Hee
    Hong, Jung Yong
    Yoon, Dok Hyun
    Suh, Cheolwon
    BLOOD, 2017, 130
  • [30] Correlation of CD8 infiltration and expression of its checkpoint proteins PD-L1 and PD-L2 with the stage of cervical carcinoma
    Carvalho, Maria O. O.
    Nicol, Alcina F.
    Oliveira, Nathalia S.
    Cunha, Cynthia B.
    Amaro-Filho, Sergio M.
    Russomano, Fabio B.
    Portari, Elizabeth A.
    Nuovo, Gerard J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (10): : 10406 - 10413
12345